Globally, an estimated 26% of the world’s population (972 million people) suffer from high blood pressure, and this prevalence is expected to increase to 29% by 2025. The high prevalence of high blood pressure poses a huge public health burden. As a leading cause of heart disease and stroke (the first and third leading causes of death globally), high blood pressure is the largest modifiable risk factor for disability-adjusted life years lost globally. Therefore, real-time monitoring of blood pressure in daily life is very necessary.
To this end, Konsung Medical developed the QD-103 blood pressure monitor, which is an alternative to the traditional mercury sphygmomanometer. It uses advanced digital technology to measure blood pressure and does not contain mercury or lead. It has the same use mode as mercury sphygmomanometer, which is more accurate, environmentally friendly and provides great convenience to doctors and patients.
Konsung medical, focus on more details of your #healthcare.
Post time: Mar-02-2022